Remicade

FDA approves Celltrion’s subcutaneous Remicade biosimilar for IBD
FDA approves Celltrion’s subcutaneous Remicade biosimilar for IBD
Pharm
Celltrio
Zymfentra
ulcerative colitis
Crohn's Disease
biosimilars
Remicade
Flag link:
J&J finalizes $25M settlement, laying Remicade antitrust allegations to rest
J&J finalizes $25M settlement, laying Remicade antitrust allegations to rest
Endpoints
JNJ
legal
Remicade
antitrust
biosimilars
Flag link:
J&J, BMS arthritis drugs lowered death risk among COVID patients in federal study
J&J, BMS arthritis drugs lowered death risk among COVID patients in federal study
Fierce Pharma
JNJ
Bristol Myers Squibb
COVID-19
rheumatoid arthritis
clinical trials
Orencia
Remicade
Flag link:
Pfizer, Johnson & Johnson settle high-profile Remicade biosim lawsuit on undisclosed terms
Pfizer, Johnson & Johnson settle high-profile Remicade biosim lawsuit on undisclosed terms
Fierce Pharma
Pfizer
JNJ
Remicade
biosimilars
legal
Flag link:
Pfizer's Unheralded Franchise That's Worth Billions of Dollars
Pfizer's Unheralded Franchise That's Worth Billions of Dollars
Motley Fool
Pfizer
biosimilars
Humira
Inflectra
Remsima
Remicade
autoimmune disease
JNJ
Flag link:
J&J offered doctors free services and profit-making advice to boost Remicade scripts: whistleblower suit
J&J offered doctors free services and profit-making advice to boost Remicade scripts: whistleblower suit
Fierce Pharma
JNJ
Remicade
Simponi
kickbacks
whistleblower lawsuits
Flag link:
J&J's Remicade losing ground in Quebec health plan despite court victory
J&J's Remicade losing ground in Quebec health plan despite court victory
Yahoo/Reuters
JNJ
Canada
Quebec
Remicade
autoimmune disease
Flag link:
Celltrion taps Lonza to produce some of its Remicade biosimilar
Celltrion taps Lonza to produce some of its Remicade biosimilar
Biopharma Dive
Celltrion
Lonza
Remicade
biosimilars
Remsima
Flag link:
FTC Issues Civil Investigative Demand to Johnson & Johnson Regarding Remicade
FTC Issues Civil Investigative Demand to Johnson & Johnson Regarding Remicade
Big Molecule Watch
Remicade
JNJ
Pfizer
antitrust
Walgreens
Kroger
Flag link:
FTC investigates J&J contracts regarding the drugmaker's blockbuster Remicade
FTC investigates J&J contracts regarding the drugmaker's blockbuster Remicade
Endpoints
FTC
JNJ
Remicade
antitrust
biosimilars
Pfizer
Inflectra
Flag link:
6 Things Johnson & Johnson Wants You to Know About Its Pharmaceuticals
6 Things Johnson & Johnson Wants You to Know About Its Pharmaceuticals
Motley Fool
JNJ
devices
Remicade
consumer health
immuno-oncology
Flag link:
UnitedHealthcare gives Remicade biosims a leg up with changes to Medicare plans
UnitedHealthcare gives Remicade biosims a leg up with changes to Medicare plans
Fierce Pharma
CMS
UnitedHealthcare
Medicare
JNJ
Remicade
biosimilars
Pfizer
Merck
Flag link:
Pfizer lawsuit could clear path for biosimilars
Pfizer lawsuit could clear path for biosimilars
Medical Marketing and Media
Pfizer
JNJ
Remicade
biosimilars
Inflectra
Flag link:
Judge Denies J&J Motion to Dismiss Pfizer Lawsuit Over Remicade
Judge Denies J&J Motion to Dismiss Pfizer Lawsuit Over Remicade
RAPS.org
Pfizer
JNJ
Remicade
biosimilars
Inflectra
Flag link:
Pfizer Wins Remicade Patent Case Over J&J
Pfizer Wins Remicade Patent Case Over J&J
RAPS.org
Pfizer
Celltrion
JNJ
Janssen
patents
Remicade
Flag link:
Amgen Announces Top-Line Data From Remicade Biosimilar Study
Amgen Announces Top-Line Data From Remicade Biosimilar Study
Yahoo/Zacks.com
Amgen
ABP 710
JNJ
Merck
Remicade
biosimilars
rheumatoid arthritis
Flag link:
Novartis touts effectiveness, safety of autoimmune drug copies
Novartis touts effectiveness, safety of autoimmune drug copies
Yahoo/Reuters
Novartis
biosimilars
JNJ
Remicade
Amgen
Enbrel
autoimmune disease
Flag link:
Can Johnson & Johnson Replace Remicade for $100 Million Upfront?
Can Johnson & Johnson Replace Remicade for $100 Million Upfront?
Motley Fool
JNJ
Remicade
TD-1473
Theravance
JAK inhibitors
inflammatory bowel disease
Flag link:
Remicade biosims from Pfizer, Merck unlikely to turn the tide in 2018: analyst
Remicade biosims from Pfizer, Merck unlikely to turn the tide in 2018: analyst
Fierce Pharma
Remicade
biosimilars
Pfizer
Merck
JNJ
Flag link:
Biosimilars Council Sides with Pfizer in Antitrust Dispute with J&J
Biosimilars Council Sides with Pfizer in Antitrust Dispute with J&J
JD Supra
biosimilars
Pfizer
JNJ
antitrust
Remicade
Inflectra
Flag link:

Pages